2022-01-01 00:00:00
The oral microbiome and breast cancer and nonmalignant breast disease, and its relationship with the fecal microbiome in the Ghana Breast Health StudyCategories
View AllConditions
View AllDefinitions
View AllGuides & Resources
View AllInterventions
View AllMicrobes
View AllMetals
View AllResearch Feeds
View AllKaren Pendergrass, Standards Team
About
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Recent Posts
2021-01-01 00:00:00
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease2021-01-01 00:00:00
Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort2021-01-01 00:00:00
Association between Parkinson’s disease and the faecal eukaryotic microbiota2021-01-01 00:00:00
Deep nasal sinus cavity microbiota dysbiosis in Parkinson’s disease2021-01-01 00:00:00
An analysis of the characteristics of the intestinal flora in patients with Parkinson’s disease complicated with constipation2021-01-01 00:00:00
Analysis of the Gut Mycobiome in Adult Patients with Type 1 and Type 2 Diabetes Using Next-Generation Sequencing (NGS) with Increased Sensitivity-Pilot Study2021-01-01 00:00:00
Associations Between Endometriosis and Gut MicrobiotaThis study examines the association between endometriosis and gut microbiota, highlighting significant differences in microbial diversity and composition. Women with endometriosis showed altered gut microbial profiles compared to healthy controls, with specific bacterial shifts linked to gastrointestinal symptoms and hormonal therapy. These findings suggest microbiota-targeted therapies may benefit endometriosis management.
2021-01-01 00:00:00
Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosisThis study explores the gut microbiota imbalance and its correlations with hormone and inflammatory factors in stage 3/4 endometriosis. Key findings reveal distinct microbial shifts linked to hormonal dysregulation and inflammation, offering insights into disease mechanisms and potential microbiome-targeted therapeutic approaches.
2021-01-01 00:00:00
Altered Composition of Microbiota in Women with Ovarian Endometrioma: Microbiome Analyses of Extracellular Vesicles in the Peritoneal Fluid